Genmab shares rise 8% as AbbVie’s combination therapy confirms reduced risk of death
智通财经2026/10/06 07:21Genmab shares rose by 8% after its blood cancer drug combination, developed in collaboration with AbbVie, was shown to reduce the risk of death.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi raises AMD target price to $800
Citi has raised AMD (AMD.US) target price from $575 to $800.
Vido Energy Group CEO: Upcoming tenders will clarify the scale and location of oil releases in the coming weeks
Vitol Energy Group CEO: Upcoming tenders to be announced in the next few weeks will clarify how much oil will be released and the release locations.
Vito Energy Group CEO says oil release announcement did not specify location and quantity.
The CEO of Vitor Energy Group stated: "That was not a completely transparent announcement, as it did not clearly specify where and which oil would be released."
The CEO of Weiduo Energy Group says that Middle East liquefied natural gas production is about 25% of capacity.
The CEO of Vido Energy Group stated that the current liquefied natural gas output in the Middle East is about 25% of its capacity.
Crypto prices
More
